FIELD: medicine, veterinary science.
SUBSTANCE: invention relates to the field of veterinary science. Vaccine contains dissolvent and antigen on the basis of cultures Escherichia coli. As dissolvent, vaccine contains physiological solution, and as antigen - antigen of strain E. coli "B-5" with content of 1.0×106-2.0×106 microbial cells in 1 cm3 of physiological solution.
EFFECT: vaccine has highly immunogenic and protective properties as a result of forming antitoxic immunity.
4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTION OF COLIBACILLOSIS IN CHICKEN | 2012 |
|
RU2498817C1 |
| LIVE VACCINE AGAINST COLIBACTERIOSIS IN CALVES | 2005 |
|
RU2288006C1 |
| ALIVE VACCINE AGAINST PORCINE COLIBACTERIOSIS | 2003 |
|
RU2248806C1 |
| STRAIN ESCHERICHIA COLI B-5 USED FOR PREPARING THERMOLABILE EXOTOXIN | 2003 |
|
RU2248393C2 |
| VACCINE FOR ROTA-, CORONAVIRAL INFECTION AND CATTLE COLIBACILLOSIS | 2018 |
|
RU2708891C1 |
| RECOMBINANT PLASMID DNA pPA-OPRF-ETA CODING SYNTHESIS OF RECOMBINANT PROTEIN OPRF-ETA Pseudomonas aeruginosa, STRAIN Escherichia coli PA-OPRF-ETA PRODUCING RECOMBINANT PROTEIN OPRF-ETA Pseudomonas aeruginosa AND METHOD FOR PREPARING RECOMBINANT PROTEIN OPRF-ETA Pseudomonas aeruginosa | 2012 |
|
RU2529359C2 |
| VACCINE AGAINST VISCERAL MYCOSIS CAUSED BY FUNGUS OF GENUS MUCOR RACEMOSUS IN AGRICULTURAL ANIMALS | 2004 |
|
RU2270694C1 |
| AVIAN GLASSER'S DISEASE VACCINE INACTIVATED IN THE FORM OF “HEMOVAC” SUSPENSION | 2020 |
|
RU2752315C1 |
| ASSOCIATED COLIBACILLOSIS, STREPTOCOCCOSIS AND RABBIT VIRAL HEMORRHAGIC DISEASE VACCINE | 2010 |
|
RU2443775C1 |
| STRAIN MUCOR RACEMOSUS 195 USED IN PREPARING IMMUNOGENIC PREPARATIONS AGAINST MUCOROSIS IN AGRICULTURAL ANIMALS | 2003 |
|
RU2248392C2 |
